Fundai

Sobhan Oncology Pharmaceutical Company (DSANKO) cash flow statement

Operating, investing and financing cash flows, and the closing balance

Ticker
DSANKO
Industry
Pharmaceuticals
Market
Iran Fara Bourse

Latest periods

Latest 9-month periods, in million rials
ItemTo 1405/06/31To 1404/06/31To 1403/06/31To 1402/06/31To 1401/06/31To 1400/09/30
Cash generated from operations-6,358,238-1,834,082-1,551,136-1,095,849304,772-234,429
Cash payments for income tax-122,645-119,085-45,602-32,2370-69,812
Net cash inflow (outflow) from operating activities-6,480,883-1,953,167-1,596,738-1,128,086304,772-304,241
Cash receipts from sale of property, plant and equipment344,00000000
Cash payments for purchase of property, plant and equipment-65,867-19,192-37,120-42,432-32,052-91,961
Cash receipts from dividends6222501,3056399361,383
Cash receipts from interest on other investments21323,7101,7192,5721,5771,410
Net cash inflow (outflow) from investing activities278,968-545,434265,904-40,516-29,670-93,330
Net cash inflow (outflow) before financing activities-6,201,915-2,498,601-1,330,834-1,168,602275,102-397,571
Cash receipts from facilities7,156,6014,535,8125,967,3175,984,226832,7091,200,925
Cash payments for principal of loans-2,568,743-3,034,007-4,024,842-3,848,605-568,425-252,065
Cash payments for interest on loans-1,153,292-726,223-812,434-552,221-416,383-572,140
Cash payments for dividends-6,309-40,147-9,120-37,791-18,330-105,006
Net cash inflow (outflow) from financing activities3,428,2572,395,8411,209,9981,408,360-165,774281,630
Net increase (decrease) in cash-2,773,658-102,760-120,836239,758109,328-115,941
Cash balance at beginning of year3,940,700300,333413,704341,873122,201239,059
Cash balance at end of year1,167,042201,477307,228594,085228,805122,201
Non-cash transactions6,754,0815,320,6491,302,9422,072,443699,207596,710

Reporting periods

44 periods are on file for this report, from the period ending 1393/12/29 to the period ending 1405/06/31.